Smith+Nephew
[PUBLIC]Service & Cobot Robotics · HQ: Watford, England · Est. 1856 · 1 model registered · 1 deployments
As of Sep 2026, DEPLOY verifies Smith+Nephew: 1 model, 1 deployment across 1 region. 3 sources back the record.
Ownership
PUBLIC
Capital / Funding
Undisclosed
Headquarters
Watford, England
IP / Patents
Undisclosed
Platform Models
1
Audited Incidents
0
Overview
Smith+Nephew is a British multinational medical technology company headquartered in Watford, England, and a FTSE 100 constituent (LSE: SN, NYSE: SNN). Founded in 1856 by Thomas James Smith in Kingston upon Hull, the company develops the CORI handheld robotic surgical platform for orthopaedic procedures including partial and total knee arthroplasty and shoulder arthroplasty. Smith+Nephew reported $6.16B revenue in 2025 and employs approximately 18,000 people across 100+ countries.
Clean safety record across 1 verified deployment. Deployment footprint remains limited relative to category peers.
- PUBLIC
- SURGICAL
Key Facts
Safety & Regulatory Posture
No incidents on record for Smith+Nephew.
Evidentiary Regulatory Filings & Recalls
fda_510kfda 510k · us_fdacleared2020-01-01Linked models: CORI
Leadership & Founders
Current Program Leadership & Executives
CEO
President, Orthopaedics
Chairman
Founder
Founding Team
cofounder · no longer at company
Partnerships & Commercial Deployments
Key Recurring Partners
Recent Verified Partnerships
- Brainlab x Smith+Nephew (Orthopaedic Joint Reconstruction)Nov 1, 2019
MOST RECENT · Brainlab x Smith+Nephew (Orthopaedic Joint Reconstruction) · 2019-11-01 · with Brainlab · OPERATING
Operator Customers & Fleet Integrators
Platform Models
Deployments
Sectors & Applications
FAQ
What is Smith+Nephew?
Smith+Nephew is a British multinational medical technology company headquartered in Watford, England, and a FTSE 100 constituent (LSE: SN, NYSE: SNN). Founded in 1856 by Thomas James Smith in Kingston upon Hull, the company develops the CORI handheld robotic surgical platform for orthopaedic procedures including partial and total knee arthroplasty and shoulder arthroplasty. Smith+Nephew reported $6.16B revenue in 2025 and employs approximately 18,000 people across 100+ countries.
What does Smith+Nephew make?
Smith+Nephew has 1 robot model on the DEPLOY registry: CORI (Smith+Nephew builds both physical robots and the AI that runs them).
Is Smith+Nephew publicly traded?
Smith+Nephew is not an independent public company; it has been acquired, per the DEPLOY registry.
Who competes with Smith+Nephew?
On the DEPLOY registry, peer companies to Smith+Nephew building in the same form factors include Brainlab, EndoQuest Robotics, Intuitive Surgical, LEM Surgical.
Who is the CEO of Smith+Nephew?
Deepak Nath is the ceo of Smith+Nephew, per the DEPLOY registry.
How can I invest in Smith+Nephew?
Smith+Nephew has no separately traded stock; it has been acquired.
Who owns Smith+Nephew?
Smith+Nephew has been acquired and is no longer independently owned.
Where does Smith+Nephew operate robots?
Smith+Nephew operates 1 verified deployment, including at United States.
How many robots has Smith+Nephew deployed?
DEPLOY has 1 verified Smith+Nephew deployment on record at sites including United States. That is a count of distinct field deployments each backed by sourced evidence, not a manufacturer's claimed unit total; it updates as new sites are verified.
Is Smith+Nephew a top robotics company?
On DEPLOY's intelligence score, which blends verified deployments, funding, hiring, media, safety, and IP signals, Smith+Nephew ranks in roughly the top 61% of companies tracked by the registry.
Is Smith+Nephew safe?
Smith+Nephew has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.